TNFSF10 and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) stands out among the large number of molecules being investigated for cancer therapy due to its ability to selectively induce cytotoxicity in malignant cells without harming healthy tissues [1].